万维书刊网微信二维码

扫微信,关注编辑QQ!

投稿问答最小化  关闭

您的位置:万维书刊网 >>医卫科学>>神经病学
您的位置:万维书刊网 >>国内sci期刊>>医药卫生

转化神经变性病(英文)(Translational Neurodegeneration)(OA期刊) (官网投稿)

简介
  • 期刊简称
  • 参考译名
  • 核心类别 CSCD核心(2025-2026), 高质量科技期刊(T2-2025), SCIE核心, 目次收录(维普), 知网外文库,外文期刊,
  • IF影响因子
  • 自引率
  • 主要研究方向展开更多

主要研究方向:

等待设置主要研究方向

《转化神经变性病(英文)》(Translational Neurodegeneration)(年刊),创刊于2012年,是由上海交通大学医学院附属瑞金医院主办、上海交通大学主管的专注于神经变性病转化研究的开放获取出版期刊。主要报道神经变性病领域的流行病学、发病机制、诊断、治疗等方面的最新进展。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、官网网址:

https://link.springer.com/journal/40035

(主办单位微信公众号信息)

3、投稿系统:

https://submission.springernature.com/new-submission/40035/3?

4、出刊日期:年刊,一年出版一期。

5、主办单位微信公众号:上海瑞金医院神经内科

2026129日星期四

                        

 

Submission guidelines

【官网信息】

 

These submission guidelines will help you prepare to publish your research successfully in Translational Neurodegeneration.

First steps

Before you submit your manuscript, we recommend you familiarise yourself with the following:

Aims and scope - Make sure you submit to the most suitable journal

Fees and funding - Understand costs and funding options

Licensing and copyright - Understand the copyright agreement

Get ready to submit

To give your manuscript the best chance of publication, follow these editorial policies and formatting guidelines:

Prepare your manuscript - Formatting rules for article types

Language editing - Make sure your manuscript is accurate and readable

Prepare supporting information - Everything you need to complete your submission

Editorial policies - Read our editorial policies

Submit and promote

Now you’re ready to submit your manuscript.

Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.

Peer review policy - Who decides whether my work will be accepted?

Manuscript transfers - Want to submit to a different journal?

Promote your publication - Spread the word about your research

Aims and scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Topics of interest include but are not limited to the following areas of neurodegenerative diseases:

Epidemiology and pathogenesis

Research into diagnosis and prevention

Research into the disease pathogenesis

Development of new drugs and cell therapy

Drug delivery

Rehabilitation

Translational Neurodegeneration offers the opportunity for scientists, clinicians and physician-scientists to publish their research and clinical trials in a journal which is applicable to their specific field.

Fees and funding

Translational Neurodegeneration is an open access journal.

Publishing your research open access in a journal makes your research publicly available for everyone to read. Readers do not have to pay for access; there are no subscription charges or registration barriers. This means more readers, citations and impact for research published this way.

Benefits of open access

Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work:

......

更多详见:

https://link.springer.com/journal/40035/submission-guidelines

  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP备2021036211号

     纯自助论文投稿平台    E-mail:1121090112@qq.com;eshukan@163.com


投稿问答最小化  关闭

投稿有问题?问问网友吧!

问答